Welcome, Guest |
TOPIC:
FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hep B 7 years 6 months ago #22000
FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk www.raps.org/Regulatory-Focus/News/2016/...B-Reactivation-Risk/ So if one had Hepatitis B would you still treat? I'd take that chance since a very small number of cases were reported. By the way, that warning was from the Food and Drug Administration which is USA based. I just got my prescription from Dr Freeman and I plan on getting my meds. Never had hep B anyway. Just information here. Genotype 1A ALT 473 AST 226 Virus Load 3,119,030 Results as of May-2016 5 week viral load/undetected as of 12/02/2016 Liver Biopsy Results from Feb 2013 Portal/Periportal chronic inflammation and mild interface hepatitis (Grade 2) Focal Lobular chronic inflammation (Grade 1) Portal/Periportal fibrosis (stage 1-2 trichrome and reticulin stains utilized) Negative Iron stains. | |
FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hep B 7 years 6 months ago #22087
Hi Tommy This is a bit of a storm ina teacup. There's another post on the forum bout this where Dr James addresses it. I have had Hep B and it worried me a bit but now I'm happy again Genotype 1a Diagnosed in 2004, had HCV for all my adult life. Until 2016!!!! Harvoni treatment, started 19 March 2016 4 week results Bilirubin 12 down from 14 pre treatment, Gamma 25 down from 52, ALT 19 down from 63, AST 19 down from 47, VL <15 down from a lazy 6 million or so EOT Results Bilirubin 10, GGT 18, ALT 19, AST 21, VL UND 12 Weeks post EOT Bilirubin 11, GGT 16, ALT 22, AST 20, VL UND Cured baby | |
Time to create page: 0.063 seconds